Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
暂无分享,去创建一个
A. Rothenberger | T. Meyer | A. Becker | U. Ravens-Sieberer | H. Hölling | Biyao Wang | R. Schlack | Jan Schulz | Franziska Huber
[1] M. Solmi,et al. Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study , 2022, World psychiatry : official journal of the World Psychiatric Association.
[2] Tao Liu,et al. Unsaturated fatty acids in mental disorders: An umbrella review of meta-analyses. , 2022, Advances in Nutrition.
[3] S. Faraone,et al. Association between ADHD and vision problems. A systematic review and meta-analysis , 2022, Molecular Psychiatry.
[4] W. Cubała,et al. Commentary concerning treatment of depression in patients with heart failure according to 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2022, European journal of preventive cardiology.
[5] P. Lichtenstein,et al. The role of ADHD genetic risk in mid-to-late life somatic health conditions , 2022, Translational Psychiatry.
[6] C. Correll,et al. Associations between mental and physical conditions in children and adolescents: An umbrella review , 2022, Neuroscience & Biobehavioral Reviews.
[7] L. Snetselaar,et al. Association of Food Allergy, Respiratory Allergy, and Skin Allergy with Attention Deficit/Hyperactivity Disorder among Children , 2022, Nutrients.
[8] S. Bölte,et al. Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis , 2021, Psychological Medicine.
[9] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.
[10] Marina De Vos,et al. Longitudinal Associations Between Symptoms of ADHD and BMI From Late Childhood to Early Adulthood , 2021, Pediatrics.
[11] E. Bandak,et al. Efficacy and Safety of Polyunsaturated Fatty Acids Supplementation in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents: A Systematic Review and Meta-Analysis of Clinical Trials , 2021, Nutrients.
[12] York Hagmayer,et al. Physical Activity Improves Mental Health in Children and Adolescents Irrespective of the Diagnosis of Attention Deficit Hyperactivity Disorder (ADHD)—A Multi-Wave Analysis Using Data from the KiGGS Study , 2021, International journal of environmental research and public health.
[13] Steffen E. Petersen,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.
[14] Xue-Ni Xie,et al. Global prevalence of obesity, overweight and underweight in children, adolescents and adults with autism spectrum disorder, attention‐deficit hyperactivity disorder: A systematic review and meta‐analysis , 2020, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[15] B. Franke,et al. Genome-Wide DNA Methylation Patterns in Persistent Attention-Deficit/Hyperactivity Disorder and in Association With Impulsive and Callous Traits , 2020, Frontiers in Genetics.
[16] A. Rothenberger,et al. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[17] F. Baumgarten,et al. ADHS bei Kindern und Jugendlichen in Deutschland – Querschnittergebnisse aus KiGGS Welle 2 und Trends , 2018 .
[18] S. Mahmoud,et al. Dyslipidemia and Fatty Liver Disease in Overweight and Obese Children , 2018, Journal of obesity.
[19] S. Avcil. Association between altered lipid profiles and attention deficit hyperactivity disorder in boys , 2018, Nordic journal of psychiatry.
[20] B. Kurth. Editorial: Neues von und über KiGGS , 2018 .
[21] T. Lampert,et al. Messung des sozioökonomischen Status und des subjektiven sozialen Status in KiGGS Welle 2 , 2018 .
[22] A. S. Rosario,et al. KiGGS Wave 2 longitudinal component – data collection design and developments in the numbers of participants in the KiGGS cohort , 2018, Journal of health monitoring.
[23] C. Pariante,et al. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-analysis of Clinical Trials and Biological Studies , 2018, Neuropsychopharmacology.
[24] P. Brambilla,et al. The Role of Omega-3 Fatty Acids in Developmental Psychopathology: A Systematic Review on Early Psychosis, Autism, and ADHD , 2017, International journal of molecular sciences.
[25] C. Poethko-Müller,et al. Neue Daten für Taten.Die Datenerhebung zur KiGGS Welle 2 ist beendet , 2017 .
[26] T. Banaschewski,et al. Attention-Deficit/Hyperactivity Disorder. , 2017, Deutsches Arzteblatt international.
[27] C. Pariante,et al. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies , 2017 .
[28] Jan K. Buitelaar,et al. Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.
[29] A. Rothenberger,et al. Erratum to: Six years ahead: a longitudinal analysis regarding course and predictive value of the Strengths and Difficulties Questionnaire (SDQ) in children and adolescents , 2015, European Child and Adolescent Psychiatry.
[30] A. Rothenberger,et al. Six years ahead: a longitudinal analysis regarding course and predictive value of the Strengths and Difficulties Questionnaire (SDQ) in children and adolescents , 2015, European Child & Adolescent Psychiatry.
[31] J. Nigg,et al. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. , 2014, Clinical psychology review.
[32] A. Thapar,et al. Practitioner Review: What have we learnt about the causes of ADHD? , 2013, Journal of Child Psychology and Psychiatry, and Allied Disciplines.
[33] K. Lesch,et al. A lifetime of attention-deficit/hyperactivity disorder: diagnostic challenges, treatment and neurobiological mechanisms , 2011, Expert review of neurotherapeutics.
[34] J. Thome,et al. Modified magnesium and lipoproteins in children with attention deficite hyperactivity disorder (ADHD) , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[35] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[36] T. Banaschewski,et al. Psychometric Validity of the Strengths and Difficulties Questionnaire-Dysregulation Profile , 2010, Psychopathology.
[37] Nehemia Kaysar,et al. Methylphenidate Has Positive Hypocholesterolemic and Hypotriglyceridemic Effects: New Data , 2009, Journal of clinical pharmacology.
[38] B. Kurth,et al. How often are German children and adolescents diagnosed with ADHD? Prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS) , 2008, European Child & Adolescent Psychiatry.
[39] A. Berg,et al. Frequency of secondary dyslipidemia in obese children , 2008, Vascular health and risk management.
[40] Gert B. M. Mensink,et al. The challenge of comprehensively mapping children's health in a nation-wide health survey: Design of the German KiGGS-Study , 2008, BMC public health.
[41] B. Horta,et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.
[42] C. Scheidt-Nave,et al. Biochemische Messparameter im Kinder- und Jugendgesundheitssurvey (KiGGS) , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[43] H. Hölling,et al. Der Kinder- und Jugendgesundheitssurvey (KiGGS): Studienmanagement und Durchführung der Feldarbeit , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[44] B. Kurth. Der Kinder- und Jugendgesundheitssurvey (KiGGS): Ein Überblick über Planung, Durchführung und Ergebnisse unter Berücksichtigung von Aspekten eines Qualitätsmanagements , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[45] H. Knopf,et al. Arzneimittelanwendung bei Kindern und Jugendlichen , 2007, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[46] B. Kurth. [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): an overview of its planning, implementation and results taking into account aspects of quality management]. , 2007, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.
[47] B. Kurth. Symposium zur Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland , 2006, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.
[48] S. Chalon. Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.
[49] Aneeq Ahmad,et al. Decrease in neuron size in docosahexaenoic acid-deficient brain. , 2002, Pediatric neurology.
[50] H. Meltzer,et al. Lower serum high‐density lipoprotein cholesterol (HDL‐C) in major depression and in depressed men with serious suicidal attempts: relationship with immune‐inflammatory markers , 1997, Acta psychiatrica Scandinavica.
[51] P. Cowen,et al. Low Serum Cholesterol and Suicide , 1993, British Journal of Psychiatry.
[52] H. Engelberg,et al. Low serum cholesterol and suicide , 1992, The Lancet.
[53] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .